EMVision Medical Devices Ltd (EMV.AX)
AUD 1.89
(-0.53%)
AUD 1.89
(-0.53%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 11.21 Million | 6.97 Million | 4.36 Million | 1.69 Million | 1.55 Million | 1.41 Million |
| Cost of Revenue | - | 342 Thousand | 243.34 Thousand | 113.95 Thousand | - | - |
| Gross Profit | 11.21 Million | 6.63 Million | 4.11 Million | 1.58 Million | 1.55 Million | 1.41 Million |
| Operating Expenses | 12.83 Million | 10.58 Million | 10.22 Million | 10.07 Million | 5.11 Million | 4.37 Million |
| Selling, General and Administrative Expenses | 8.13 Million | 8.57 Million | 7.89 Million | 7.36 Million | 2.17 Million | 2.12 Million |
| Research and Development Expenses | 4.69 Million | 2.01 Million | 2.32 Million | 2.7 Million | 2.93 Million | 1.96 Million |
| Other Expenses | - | 6.97 Million | 4.36 Million | 1.74 Million | 1.6 Million | 288.88 Thousand |
| Cost and Expenses | 12.83 Million | 10.92 Million | 10.46 Million | 10.18 Million | 5.11 Million | 4.37 Million |
| Operating Income | -1.61 Million | -10.92 Million | -10.46 Million | -10.18 Million | -5.11 Million | -2.95 Million |
| Interest Expense | 115.71 Thousand | 35.27 Thousand | 18.12 Thousand | 9837.00 | 597.00 | 761.00 |
| Income Tax Expense | 697.73 Thousand | -2.5 Million | -1.99 Million | -1.28 Million | -657.7 Thousand | -279.13 Thousand |
| Earnings before Tax | -2.03 Million | -6.37 Million | -8.09 Million | -9.67 Million | -4.13 Million | -2.95 Million |
| Net Income | -2.72 Million | -3.87 Million | -6.1 Million | -8.39 Million | -3.47 Million | -2.95 Million |
| Earnings Per Share Basic | -0.03 | -0.05 | -0.08 | -0.12 | -0.06 | -0.06 |
| Earnings Per Share Diluted | -0.03 | -0.05 | -0.08 | -0.12 | -0.06 | -0.06 |
| Weighted Average Shares Outstanding | 80.43 Million | 77.71 Million | 75.19 Million | 70.09 Million | 61.4 Million | 46.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 80.43 Million | 77.71 Million | 75.19 Million | 70.09 Million | 61.4 Million | 46.95 Million |
| Gross Margin | 1.00 | 0.95 | 0.94 | 0.93 | 1.00 | 1.00 |
| EBIT Margin | -0.19 | -1.52 | -2.34 | -5.93 | -3.30 | -2.09 |
| Profit Margin | -0.24 | -0.56 | -1.40 | -4.94 | -2.24 | -2.09 |
| EBITDA | -2.09 Million | -3.49 Million | -7.83 Million | -9.55 Million | - | - |
| Earnings Before Tax Margin | -0.14 | -1.57 | -2.40 | -5.99 | -3.30 | -2.09 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4.57 Million | - | 6.64 Million | 6.97 Million | 2.02 Million | 4.94 Million |
| Cost of Revenue | 207.81 Thousand | 410.58 Thousand | 202.76 Thousand | 342 Thousand | 189.49 Thousand | 152.51 Thousand |
| Gross Profit | 4.36 Million | -410.58 Thousand | 6.44 Million | 6.63 Million | 1.83 Million | 4.79 Million |
| Operating Expenses | 6.7 Million | 13.06 Million | 6.12 Million | 10.58 Million | 5.02 Million | 5.56 Million |
| Selling, General and Administrative Expenses | 3.86 Million | - | 4.27 Million | - | 3.8 Million | 4.77 Million |
| Research and Development Expenses | 2.84 Million | - | 1.85 Million | - | 1.22 Million | 789.03 Thousand |
| Other Expenses | - | - | - | 6.97 Million | - | - |
| Cost and Expenses | 6.7 Million | 13.47 Million | 6.33 Million | 10.92 Million | 5.21 Million | 5.71 Million |
| Operating Income | -2.13 Million | -13.47 Million | -6.33 Million | -10.92 Million | -5.21 Million | -5.71 Million |
| Interest Expense | 56.06 Thousand | 115.71 Thousand | 59.65 Thousand | 35.27 Thousand | 16.6 Thousand | 18.66 Thousand |
| Income Tax Expense | 233.53 Thousand | -6.14 Million | -3.96 Million | -2.5 Million | - | -2.5 Million |
| Earnings before Tax | -2.38 Million | -8.87 Million | -4.07 Million | -6.37 Million | -3.11 Million | -3.25 Million |
| Net Income | -2.61 Million | -2.72 Million | -112.6 Thousand | -3.87 Million | -3.11 Million | -758.5 Thousand |
| Earnings Per Share Basic | -0.03 | - | -0.00 | - | -0.04 | -0.01 |
| Earnings Per Share Diluted | -0.03 | - | -0.00 | - | -0.04 | -0.01 |
| Weighted Average Shares Outstanding | 82.91 Million | 80.43 Million | 77.93 Million | 77.71 Million | 77.91 Million | 83.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 82.93 Million | 80.43 Million | 77.93 Million | 77.71 Million | 77.91 Million | 83.88 Million |
| Gross Margin | 0.95 | - | 0.97 | 0.95 | 0.91 | 0.97 |
| EBIT Margin | -0.57 | - | -0.92 | - | -2.48 | -1.12 |
| Profit Margin | -0.57 | - | -0.02 | -0.56 | -1.53 | -0.15 |
| EBITDA | -2.6 Million | - | -6.12 Million | - | -5.02 Million | -5.56 Million |
| Earnings Before Tax Margin | -0.47 | - | -0.95 | -1.57 | -2.57 | -1.16 |
REZ
DECIPHER
AZNVF
BOTX
600218
2106